Also called: Inborn genetic brain disorders
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Genetic Brain Disorders
A genetic brain disorder is caused by a variation or a mutation in a gene. A variation is a different form of a gene. A mutation is a change in a gene. Genetic brain disorders affect the development and function of the brain.
Some genetic brain disorders are due to random gene mutations or mutations caused by environmental exposure, such as cigarette smoke. Other disorders are inherited, which means that a mutated gene or group of genes is passed down through a family. They can also be due to a combination of both genetic changes and other outside factors.
Some examples of genetic brain disorders include:
- Leukodystrophies
- Phenylketonuria
- Tay-Sachs disease
- Wilson disease
Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain development and function. These brain disorders can cause serious problems that affect the nervous system. Some have treatments to control symptoms. Some are life-threatening.
It sits within Brain and Nerves, Genetics/Birth Defects and Metabolic Problems.
The lead U.S. institute for this subject is the National Institute of Neurological Disorders and Stroke.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Genetic Brain Disorders
2,991 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With PhenylketonuriaAgios Pharmaceuticals, Inc.
- A Study of SGT-212 Gene Therapy in Friedreich's AtaxiaSolid Biosciences Inc.
- The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of MetabolismNational Human Genome Research Institute (NHGRI)
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisAzafaros B.V.
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)Azafaros B.V.
- Effects of Sirolimus on Asymptomatic ApoE4 CarriersUniversity of Missouri-Columbia
Research already completed
- Inherited Diseases, Caregiving, and Social NetworksNational Human Genome Research Institute (NHGRI)
- Parkinson Disease and DBS: Cognitive Effects in GBA Mutation CarriersRutgers, The State University of New Jersey
- Epidiolex in Obsessive Compulsive Disorder and Related DisordersUniversity of Chicago
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersHoffmann-La Roche
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Genetics
- 2-hydroxyglutaric aciduria: MedlinePlus GeneticsNational Library of Medicine
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: MedlinePlus GeneticsNational Library of Medicine
- 3-methylcrotonyl-CoA carboxylase deficiency: MedlinePlus GeneticsNational Library of Medicine
- 3-methylglutaconyl-CoA hydratase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Adenylosuccinate lyase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Alpha-mannosidosis: MedlinePlus GeneticsNational Library of Medicine
- Alpha-methylacyl-CoA racemase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Alpha-N-acetylgalactosaminidase deficiency (Schindler disease): MedlinePlus GeneticsNational Library of Medicine
- Aminoacylase 1 deficiency: MedlinePlus GeneticsNational Library of Medicine
- Arginase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Arginine:glycine amidinotransferase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Argininosuccinic aciduria: MedlinePlus GeneticsNational Library of Medicine
- Aromatic l-amino acid decarboxylase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Aspartylglucosaminuria: MedlinePlus GeneticsNational Library of Medicine
- Beta-ketothiolase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Beta-mannosidosis: MedlinePlus GeneticsNational Library of Medicine
- Biotinidase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Childhood myocerebrohepatopathy spectrum: MedlinePlus GeneticsNational Library of Medicine
- Citrullinemia: MedlinePlus GeneticsNational Library of Medicine
- Coats plus syndrome: MedlinePlus GeneticsNational Library of Medicine
- Combined malonic and methylmalonic aciduria: MedlinePlus GeneticsNational Library of Medicine
- Dentatorubral-pallidoluysian atrophy: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Brain Diseases, Metabolic, InbornNational Institutes of Health
- ClinicalTrials.gov: Niemann-Pick DiseasesNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Brain Diseases, Metabolic, Inborn. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Genetic Brain Disorders, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.